Targeting the Intrinsically Disordered Structural Ensemble of α-Synuclein by Small Molecules as a Potential Therapeutic Strategy for Parkinson’s DiseaseGergely Tóth, Lisa McConlogue, Steven Finkbeiner et al.|PLoS ONE|2014Cited by 155
Identification of Small Molecule Inhibitors of Tau Aggregation by Targeting Monomeric Tau As a Potential Therapeutic Approach for TauopathiesMarcus Pickhardt, Gergely Tóth, Thomas Neumann et al.|Current Alzheimer Research|2015Cited by 63
Novel Small Molecules Targeting the Intrinsically Disordered Structural Ensemble of α-Synuclein Protect Against Diverse α-Synuclein Mediated DysfunctionsGergely Tóth, Lisa McConlogue, Thomas Neumann et al.|Scientific Reports|2019Cited by 28
Novel Small Molecules Targeting the Intrinsically Disordered Structural Ensemble of α-Synuclein Protect Against Diverse α-Synuclein Mediated DysfunctionsGergely Tóth, Lisa McConlogue, Thomas Neumann et al.|bioRxiv (Cold Spring Harbor Laboratory)|2019Cited by 2
Novel Small Molecules Targeting the Intrinsically Disordered Structural Ensemble of α-Synuclein Protect Against Diverse α-Synuclein Mediated Dysfunctions.Gergely Tóth, Lisa McConlogue, Thomas Neumann et al.|Apollo (University of Cambridge)|2019Cited by 0